Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Abbott Laboratories stock outperforms competitors on strong trading day
Shares of Abbott Laboratories rose 4.62% to $123.22 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,118.71 and the Dow Jones Industrial Average rising 0.
Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating
Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to
Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings.
Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street estimates of $11.03 billion.
Abbott Laboratories Reports Strong 2024 Financial Results
Abbott Laboratories ( ($ABT) ) has released its Q4 earnings. Here is a breakdown of the information Abbott Laboratories presented to its
11h
Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade)
Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.
2h
Abbott calls on Congress to reimburse Texas for border security efforts
Texas Gov. Greg Abbott on Thursday called on Congress to reimburse Texas for its border security operation, Operation Lone ...
1d
on MSN
Abbott's first-quarter profit forecast misses estimates, shares dip
Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...
1d
Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market
Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...
1d
Abbott Banks on Glucose Monitors, New Launches to Ride Out China, Currency Hit
(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects ...
14h
Mizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT)
Mizuho Securities analyst Anthony Petrone maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday. The company’s ...
Seeking Alpha on MSN
1d
Abbott Laboratories slips after Q4 topline miss
Abbott Laboratories (ABT) stock traded lower in the premarket on Wednesday after its Q4 2024 results fell short of Street ...
1d
Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update
For 2025, Abbott forecast organic sales growth of between 7.5% and 8.5%, as well as adjusted earnings per share of $5.05 to $5.25. Analysts expect $5.16 a share on $42 billion in sales.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
ABT
New York Stock Exchange
Q4
Earnings per share
Feedback